Literature DB >> 27505430

Bok is a genuine multi-BH-domain protein that triggers apoptosis in the absence of Bax and Bak.

Stephanie Einsele-Scholz, Silke Malmsheimer, Katrin Bertram, Daniel Stehle, Janina Johänning, Marianne Manz, Peter T Daniel, Bernhard F Gillissen, Klaus Schulze-Osthoff, Frank Essmann.   

Abstract

Entities:  

Year:  2016        PMID： 27505430     DOI： 10.1242/jcs.193946

Source DB:  PubMed          Journal:  J Cell Sci        ISSN： 0021-9533            Impact factor:   5.285


× No keyword cloud information.
  9 in total

Review 1.  Physiological and Pharmacological Control of BAK, BAX, and Beyond.

Authors:  Mark P A Luna-Vargas; Jerry Edward Chipuk
Journal:  Trends Cell Biol       Date:  2016-08-04       Impact factor: 20.808

2.  Bok regulates mitochondrial fusion and morphology.

Authors:  Jacqualyn J Schulman; Laura M Szczesniak; Eric N Bunker; Heather A Nelson; Michael W Roe; Larry E Wagner; David I Yule; Richard J H Wojcikiewicz
Journal:  Cell Death Differ       Date:  2019-04-11       Impact factor: 15.828

3.  Contribution of BH3-domain and Transmembrane-domain to the Activity and Interaction of the Pore-forming Bcl-2 Proteins Bok, Bak, and Bax.

Authors:  Daniel Stehle; Melanie Grimm; Stephanie Einsele-Scholz; Friederike Ladwig; Janina Johänning; Gerd Fischer; Bernhard Gillissen; Klaus Schulze-Osthoff; Frank Essmann
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

4.  Metastability, an emerging concept governing BOK-mediated apoptosis initiation.

Authors:  Tudor Moldoveanu; Janet H Zheng
Journal:  Oncotarget       Date:  2018-07-24

5.  SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK.

Authors:  Yang Yang; Yongjian Wu; Xiaojun Meng; Zhiying Wang; Muhammad Younis; Ye Liu; Peihui Wang; Xi Huang
Journal:  Cell Death Differ       Date:  2022-01-12       Impact factor: 12.067

6.  Modeling apoptosis resistance in CHO cells with CRISPR-mediated knockouts of Bak1, Bax, and Bok.

Authors:  Michael A MacDonald; Craig Barry; Teddy Groves; Verónica S Martínez; Peter P Gray; Kym Baker; Evan Shave; Stephen Mahler; Trent Munro; Esteban Marcellin; Lars K Nielsen
Journal:  Biotechnol Bioeng       Date:  2022-03-06       Impact factor: 4.395

7.  The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer.

Authors:  Steven Carberry; Beatrice D'Orsi; Naser Monsefi; Manuela Salvucci; Orna Bacon; Joanna Fay; Markus Rehm; Deborah McNamara; Elaine W Kay; Jochen H M Prehn
Journal:  Cell Death Dis       Date:  2018-01-26       Impact factor: 8.469

8.  Protective effect of DLX6-AS1 silencing against cerebral ischemia/reperfusion induced impairments.

Authors:  Xiamin Hu; Zifei Xiang; Wei Zhang; Zhijun Yu; Xiaoming Xin; Rong Zhang; Youping Deng; Qiong Yuan
Journal:  Aging (Albany NY)       Date:  2020-11-18       Impact factor: 5.682

9.  The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA.

Authors:  Hans-Georg Kopp; Frank Essmann; Alina Muenchow; Sandra Weller; Clemens Hinterleitner; Elke Malenke; Stefanie Bugl; Stefan Wirths; Martin R Müller; Klaus Schulze-Osthoff; Walter E Aulitzky
Journal:  Cell Death Dis       Date:  2020-08-24       Impact factor: 8.469
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.